Atlas Trials

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment for HIV/HBV-coinfection

Clinical trial NCT03425994 · UNKNOWN

Trial details

NCT number
NCT03425994
Sponsor
National Taiwan University Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Chronic Hepatitis B in HIV PatientKidney InjuryBone Diseases
Start date
2018-02-06
Primary completion
2019-02-22
Enrollment
275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.